Examples of using Quantitative composition in English and their translations into Danish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
QUALITATIVE AND QUANTITATIVE COMPOSITION.
The quantitative composition of various kinds of products, differing fat content does not change significantly.
At the same time, their quantitative composition is in equilibrium.
The veterinary medicinal product is harmful under the conditions of use stated at the time of the application for authorization, has no therapeutic effect or the applicant has not provided sufficient proof of such effect as regards the species of animal whichis to be treated, or its qualitative and quantitative composition is not as stated;
Its qualitative and quantitative composition is not as stated;
In Directives 65/65/EEC and 75/319/EEC the expressions'qualitative and quantitative particulars of the constituents' shall include particulars relating to biological activity and'qualitative and quantitative composition' shall include the composition of the product expressed in terms of biological activity.
Its qualitative or quantitative composition is not as stated; or.
Often, frequent colds, poor appetite, pallor and drowsiness in a child are a sign of anemia- a condition of the blood that causes a change in its quantitative composition in the direction of decreasing red blood cells red blood cells.
The qualitative and quantitative composition of the veterinary medicinal product is not as stated;
How to determine the qualitative and quantitative composition of matter.
Qualitative and quantitative composition in terms of the active substances and constituents of the excipient, knowledge of which is essential for proper administration of the medicinal product. The usual common name or chemical description shall be used.
That its qualitative and quantitative composition is not as declared.
OPINION OF MR LA PERGOLA- CASE C-94/98 medicinal product are produced and marketed under the same name in more than one Member State and that(ii) the differ ences between the variants,regarding the manufacturing process or the qualitative and quantitative composition of the pro duct in question, have an impact on its therapeutic effect.
Decoding it will show how the quantitative composition of bacteria has changed.
The competent authorities of the Member States shall suspend or revoke an authorization to place a medicinal product on the market where that product proves to be harmful in the normal conditions of use, or where its therapeutic efficacy is lacking, orwhere its qualitative and quantitative composition is not as declared.
In the future, when the qualitative and quantitative composition of the intestinal microflora is changed, intestinal dysbiosis can occur.
The competent authorities of the member states shall suspend or revoke an authorisation to place a" medicinal product"[5] on the market where that product proves to be harmful in the normal conditions of use, or where its therapeutic efhcacy is lacking, orwhere its qualitative and quantitative composition is not as declared.
All subsequently authorized medicinal products in the Member States shall have their quantitative composition stated in the same way for the same active ingredient.
The product can therefore be considered as having the same qualitative and quantitative composition in terms of active principle as the innovator; the same pharmaceutical form as the innovator and is also bioequivalent with the innovator, and in the light of the scientific knowledge the product does not differ significantly from the innovator in terms of efficacy and safety.
The authorisation provided for in Article 3 shall be refused if, after verification of the particulars and documents listed in Article 4, it proves that the medicinal product is harmful in the normal conditions of use, or that its therapeutic efficacy is lacking oris insufficiently substantiated by the applicant, or that its qualitative and quantitative composition is not as declared.
The particular elements of the qualitative and quantitative composition or the special manufacturing process which gives the product its particular nutritional characteristics;
Article 5 of the Directive provides that the authorisation will be refused if, after verification of the particulars and documents listed in Article 4, it proves that the medicinal product is harmful in the normal conditions of use, or that its therapeutic efficacy is lacking oris insufficiently substantiated by the applicant, or that its qualitative and quantitative composition is not as declared.
The provisions of Part 1, A of Annex I, in so far as they concern the qualitative and quantitative composition of veterinary medicinal products in respect of active substances, shall apply to the particulars provided for in paragraph 1b.
Specific character may not be restricted to qualitative or quantitative composition or to a mode of production laid down in Community or national legislation, in standards set by standardization bodies or in voluntary standards; however, this rule shall not apply where the said legislation or standard has been established in order to define the specific character of a product;
The provisions of Part 1, A of the Annex to Council Directive 81/852/EEC, in so far as they concern the qualitative and quantitative composition of veteri nary medicinal products in respe« of active ingredients, shall apply to the particulars provided for in point 2.
The medicinal product proves to be harmful under normal conditions of use;b it is lacking in therapeutic efficacy; c its qualitative and quantitative composition is not as declared; d the controls on the finished product and/or on the ingredients and the controls at an intermediate stage of the manufacturing process have not been carried out or if some other requirement or obligation relating to the grant of the authorization referred to in Article 16 has not been fulfilled.